January 5, 2021

Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.

January 21, 2021

UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.

March 16, 2021

Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.

December 17, 2020

A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.

September 29, 2020

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

May 19, 2023

The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.

February 7, 2023

The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.

February 16, 2023

The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.

September 7, 2022

University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.

February 19, 2021

This week, more than 130 hospitals, research foundations, fundraising organizations and patient advocacy groups asked the Biden administration to put cancer patients first in the next stage of the rollout. The letter, which was signed by leaders at the UC Cancer Center, says research in the past year shows that COVID-19 patients with cancer have twice the death rate than those without cancer.